Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $97.2 which represents a slight increase of $0.25 or 0.26% from the prior close of $96.95. The stock opened at $96.73 and ...

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

Porges also notes that the UK drugmaker’s interest in Gilead may suggest CEO Pascal Soriot wants to capitalise on its current position of strength “by making a large acquisition to diversify ...

Kampgrounds of America, Inc. (KOA), the largest system of privately owned campgrounds in the world, is proud to announce that ...

after CEO Pascal Soriot oversaw the construction of one of the industry’s richest drug pipelines. According to Bloomberg’s unnamed sources, AZ informally contacted Gilead last month to ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Analysts' ratings for Gilead Sciences GILD over the last quarter vary from bullish to bearish, as provided by 22 analysts. The following table encapsulates their recent ratings, offering a glimpse ...

It seemed like the whole world collectively grieved when Steve Irwin — the famed “Crocodile Hunter” — tragically died at just ...